Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Luvixasertib hydrochloride | 1610677-37-6 | 99.6% | 535.04 g/mol | C28H31ClN6O3 | 25 MG
SDP

Supplier:  Medchemexpress LLC HY101340A25MG

Encompass_Preferred

Luvixasertib hydrochloride is a selective, orally bioavailable TTK/Mps1 kinase inhibitor used in preclinical research to probe mitotic checkpoint function and to evaluate anticancer activity. It demonstrates potent in vitro inhibition of TTK and is supplied as a high-purity hydrochloride solid suitable for laboratory studies.

  • Selective TTK/Mps1 kinase inhibition for targeted research.
  • Potent in vitro activity (IC50 1.7 nM) for sensitive assays.
  • Orally bioavailable profile applicable to in vivo models.
  • Supplied as a hydrochloride solid with high purity for reproducible results.
  • Stable when stored according to recommended conditions for research use.

Catalog No. 50-002-11990


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.